Dataset: Hypothesis: Repurposing IVF screening tools to verify CRISPR-corrected induced pluripotent stem cells (iPSCs), combined with in vitro gametogenesis, may potentially create disease-free germlines that could eradicate heritable hematological mutations in future generations, such as sickle cell disease. - PathMap Experiment #000141

Interactive Data Viewer: Read, View, and Print from Day 1 Use our fully interactive viewer to view, read, and print this research data right from Day 1: https://pathmap.org/viewer.php?id=141 Artificial General Intelligence LLC Claim Evaluated: Hypothesis: Repurposing IVF screening tools to verify CRISPR-corrected induced pluripotent stem cells (iPSCs), combined with in vitro gametogenesis, may potentially create disease-free germlines that could eradicate heritable hematological mutations in future generations, such as sickle cell disease. This dataset contains the raw JSON execution trace, verified verbatim quotes, and MeSH-aligned logic gates generated by PathMap Studio's Veridical Enforcement engine. 🔍 Novel & Overlooked Insights Current curative gene therapies for SCD (e.g., exa-cel) function through hematopoietic stem cell editing, not germline alteration. CRISPR-mediated editing has been successfully applied to produce humanized DMD mouse models with clinical sequence specificity. The use of ovarian support cells (OSCs) derived from hiPSCs has been shown to improve in vitro maturation outcomes, providing a potential helper-cell platform for gametogenesis. Studies have successfully utilized CRISPR to ablate genes in chicken PGCs, demonstrating that germline-restricted suicide-gene cassettes can generate sterile surrogate hosts. The "14-day rule" and other regulatory frameworks significantly limit the current translation of embryological research into clinical reproductive medicine. Synthesis errors in ssODNs are a source of untoward variation in HDR-mediated gene editing, emphasizing the need for rigorous quality control beyond current standards. Porcine expanded potential stem cells (pEPSCs) represent a versatile platform for multiplex genome editing, showing that stem cells can maintain genetic stability through multiple edits. Mechanistic links exist between APP dosage and Notch signaling in iPSC-derived neural models, highlighting that gene dosage effects must be considered alongside mutation correction. 🧪 Extracted Custom Datapoints 📊 Suggested Experiments Assess the stability of CRISPR-corrected human PSC-derived PGCs through extended culture and epigenetic verification. Investigate the efficiency of genome editing in hiPSC-derived granulosa-like supporting cells to assess their impact on germ cell maturation. Model the transmission of corrected SCD alleles in humanized mouse models using IVG-derived gametes. 📊 Suggested Studies Longitudinal multi-generational follow-up of IVM-derived offspring to ensure epigenomic stability post-gene editing. Systematic review of global regulatory frameworks regarding germline modification for monogenic blood disorders. Comparative analysis of CRISPR-Cas9 vs. Prime Editing efficiency in correcting hemoglobinopathies within hiPSCs. 📊 Swansons Literature Based Discovery Candidates Modulating the Pcgf5-mediated totipotency exit in iPSCs could enhance the consistency of PGC specification for therapeutic germline engineering. Pcgf5 controls exit from the 2C-like totipotent state in mouse ESCs (ID: 42594811). Specification and differentiation of hPGCLCs for clinical gametogenesis (ID: 41416641). Polycomb Repressive Complex factors and 2C-like transcriptional state transitions. If Pcgf5 is critical for transitioning out of a totipotent-like state, regulating its expression might improve the yield and developmental competence of PGC-like cells derived from iPSCs for eventual therapeutic utility. 📊 Contradictions Between Evidences There is a tension between the therapeutic success of somatic CRISPR-editing (e.g., exa-cel) and the significant developmental hurdles in applying these techniques to generate viable, healthy germlines for human use. 📊 Repurposed Solutions Repurposing of FOXL2-P2A-tdTomato reporter hiPSCs and ovarian support cells (Fertilo) as a standardization framework to verify the quality and developmental competence of CRISPR-corrected iPSCs destined for IVG. Tags Attractor Table Extracted Keywords & Entities CRISPR-Cas Systems, _gates_from_crispr-cas_systems, Induced Pluripotent Stem Cells, _gates_to_induced_pluripotent_stem_cells, _gates_from_induced_pluripotent_stem_cells, Anemia, Sickle Cell, _gates_to_anemia,_sickle_cell Run Your Own Analysis PathMap is a patent-pending universal AI workbench designed to eliminate LLM hallucinations in medical research. Generate your own autonomous discovery reports at PathMap.org.